Cited by 2,543SARS-CoV-2 and COVID-19 ResearchGenomics and Phylogenetic StudiesSARS-CoV-2 detection and testing

The DOI matches its Crossref record; 16 of the 18 references it cites were found in a registry or an index.

A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology

Open access

Rambaut, Andrew, Holmes, Edward C., O’Toole, Áine, Hill, Verity, McCrone, John T., Ruis, Christopher, du Plessis, Louis, Pybus, Oliver G.·2020·Nature Microbiology

DOI 10.1038/s41564-020-0770-5PMC PMC7610519

Published version of a preprint

Open this paper in CoChat — free account Open PDF

Abstract

The ongoing pandemic spread of a new human coronavirus, SARS-CoV-2, which is associated with severe pneumonia/disease (COVID-19), has resulted in the generation of tens of thousands of virus genome sequences. The rate of genome generation is unprecedented, yet there is currently no coherent nor accepted scheme for naming the expanding phylogenetic diversity of SARS-CoV-2. Here, we present a rational and dynamic virus nomenclature that uses a phylogenetic framework to identify those lineages that contribute most to active spread. Our system is made tractable by constraining the number and depth of hierarchical lineage labels and by flagging and delabelling virus lineages that become unobserved and hence are probably inactive. By focusing on active virus lineages and those spreading to new locations, this nomenclature will assist in tracking and understanding the patterns and determinants of the global spread of SARS-CoV-2.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1038/s41564-020-0770-5

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

A novel coronavirus from patients with pneumonia in China, 2019
Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., Zhao, X., Huang, B., Shi, W., Lu, R., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001017 · Cited by 28,244
MAFFT: a novel method for rapid multiple sequence alignment based on fast Fourier transform
Katoh, K. (2002) · Nucleic Acids Research · doi:10.1093/nar/gkf436 · Cited by 17,027
IQ-TREE 2: New Models and Efficient Methods for Phylogenetic Inference in the Genomic Era
Minh, B. Q., Schmidt, H. A., Chernomor, O., Schrempf, D., Woodhams, M. D., von Haeseler, A., & Lanfear, R. (2020) · Molecular Biology and Evolution · doi:10.1093/molbev/msaa015 · Cited by 16,873
Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding
Lu, R., Zhao, X., Li, J., Niu, P., Yang, B., Wu, H., Wang, W., Song, H., Huang, B., Zhu, N., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30251-8 · Cited by 11,907
Self-citation
A new coronavirus associated with human respiratory disease in China
Wu, F., Zhao, S., Yu, B., Chen, Y.-M., Wang, W., Song, Z.-G., Hu, Y., Tao, Z.-W., Tian, J.-H., Pei, Y.-Y., et al. (2020) · Nature · doi:10.1038/s41586-020-2008-3 · Cited by 11,688
Self-citation
Ultrafast Approximation for Phylogenetic Bootstrap
Minh, B. Q., Nguyen, M. A. T., & von Haeseler, A. (2013) · Molecular Biology and Evolution · doi:10.1093/molbev/mst024 · Cited by 4,844
GISAID: Global initiative on sharing all influenza data – from vision to reality
Shu, Y., & McCauley, J. (2017) · Eurosurveillance · doi:10.2807/1560-7917.es.2017.22.13.30494 · Cited by 3,039
Maximum likelihood phylogenetic estimation from DNA sequences with variable rates over sites: Approximate methods.
Yang, Z. (1994) · Journal of Molecular Evolution · doi:10.1007/bf00160154 · Cited by 2,960
Untitled work
(1986) · Cited by 2,570
Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: Updated criteria and genotype assignment web resource
Smith, D. B., Bukh, J., KUIKEN, C. L., Muerhoff, A. S., Rice, C. M., Stapleton, J. T., & Peter Simmonds, K. (2013) · Hepatology · doi:10.1002/hep.26744 · Cited by 1,352

Show all 18 references

Sorted by citations

Items 701–800 of 1,013

SARS-CoV-2 surveillance in Italy through phylogenomic inferences based on Hamming distances derived from pan-SNPs, -MNPs and -InDels
Pasquale, A. D., Radomski, N., Mangone, I., Calistri, P., Lorusso, A., & Cammà, C. (2021) · BMC Genomics · doi:10.1186/s12864-021-08112-0 · Cited by 23
Epidemiology of COVID-19 after Emergence of SARS-CoV-2 Gamma Variant, Brazilian Amazon, 2020–2021
Nicolete, V. C., Rodrigues, P. T., Fernandes, A. R. J., Corder, R. M., Tonini, J., Buss, L., Sales, F. C. D. S., Faria, N. R., Sabino, É. C., Castro, M. C., et al. (2021) · Emerging infectious diseases · doi:10.3201/eid2803.211993 · Cited by 24
Wastewater surveillance for SARS-CoV-2 in a small coastal community: Effects of tourism on viral presence and variant identification among low prevalence populations
Rainey, A. L., Loeb, J. C., Robinson, S. E., Lednicky, J. A., McPherson, J., Colson, S., Allen, M. J., Coker, E. S., Sabo‐Attwood, T., Maurelli, A. T., et al. (2021) · Environmental Research · doi:10.1016/j.envres.2021.112496 · Cited by 24
Developing an Amplification Refractory Mutation System-Quantitative Reverse Transcription-PCR Assay for Rapid and Sensitive Screening of SARS-CoV-2 Variants of Concern
Xiong, D., Zhang, X., Shi, M., Wang, N., He, P., Dong, Z., Zhong, J., Luo, J., Wang, Y., Yu, J., et al. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.01438-21 · Cited by 24
Generalized Methodology for the Quick Prediction of Variant SARS-CoV-2 Spike Protein Binding Affinities with Human Angiotensin-Converting Enzyme II
Williams, A. H., & Zhan, C. (2022) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.1c10718 · Cited by 22
The role of viral genomics in understanding COVID-19 outbreaks in long term care facilities
Aggarwal, D., Peacock, S. J., Hamilton, W., Goodfellow, I., Török, M. E., Page, A., COG-UK Consortium, Myers, R. E., Bharucha, T., Tumelty, N. M., et al. (2021) · Apollo (University of Cambridge) · doi:10.17863/cam.73609 · Cited by 24
Impact of SARS-CoV-2 Variants on the Analytical Sensitivity of rRT-PCR Assays
Chen, Y., Han, Y., Yang, J., Ma, Y., Li, J., & Zhang, R. (2022) · Journal of Clinical Microbiology · doi:10.1128/jcm.02374-21 · Cited by 24
COVID-19 Infection With the Omicron SARS-CoV-2 Variant in a Cohort of Kidney and Kidney Pancreas Transplant Recipients: Clinical Features, Risk Factors, and Outcomes
Wong, G., Rowlandson, M., Sabanayagam, D., Ginn, A. N., Kable, K., Sciberras, F., Au, E. H. K., Draper, J. L., Arnott, A., Sintchenko, V., et al. (2022) · Transplantation · doi:10.1097/tp.0000000000004203 · Cited by 23
Improved SARS-CoV-2 sequencing surveillance allows the identification of new variants and signatures in infected patients
Grimaldi, A., Panariello, F., Annunziata, P., Giuliano, T., Daniele, M., Pierri, B., Colantuono, C., Salvi, M., Bouchè, V., Manfredi, A., et al. (2022) · Genome Medicine · doi:10.1186/s13073-022-01098-8 · Cited by 26
A comprehensive update on CIDO: the community-based coronavirus infectious disease ontology
He, Y. O., Yu, H. J., Huffman, A., Lin, Y., Natale, D. A., Beverley, J. R., Zheng, L., Perl, Y., Wang, Z., Liu, Y., et al. (2022) · Journal of Biomedical Semantics · doi:10.1186/s13326-022-00279-z · Cited by 24
Emergence and Persistent Dominance of SARS-CoV-2 Omicron BA.2.3.7 Variant, Taiwan
Shao, P., Tu, H., Gong, Y., Shu, H., Kirby, R., Hsu, L.-Y., Yeo, H.-Y., Kuo, H., Huang, Y., Lin, Y., et al. (2023) · Emerging infectious diseases · doi:10.3201/eid2904.221497 · Cited by 24
Online Phylogenetics with matOptimize Produces Equivalent Trees and is Dramatically More Efficient for Large SARS-CoV-2 Phylogenies than de novo and Maximum-Likelihood Implementations
Krämer, A., Thornlow, B. P., Ye, C., Maio, N. D., McBroome, J., Hinrichs, A. S., Lanfear, R., Turakhia, Y., & Corbett-Detig, R. B. (2023) · Systematic Biology · doi:10.1093/sysbio/syad031 · Cited by 27
Lineage replacement and evolution captured by 3 years of the United Kingdom Coronavirus (COVID-19) Infection Survey
Lythgoe, K., Golubchik, T., Hall, M. D., House, T., Cahuantzi, R., MacIntyre-Cockett, G., Fryer, H. R., Thomson, L., Nurtay, A., Ghafari, M., et al. (2023) · Proceedings of the Royal Society B Biological Sciences · doi:10.1098/rspb.2023.1284 · Cited by 28
Early Start of Oral Clarithromycin Is Associated with Better Outcome in COVID-19 of Moderate Severity: The ACHIEVE Open-Label Single-Arm Trial
Tsiakos, K., Tsakiris, A., Tsibris, G., Voutsinas, P.-M., Panagopoulos, P., Kosmidou, M. S., Petrakis, V., Gravvani, A., Gkavogianni, T., Klouras, E., et al. (2021) · Infectious Diseases and Therapy · doi:10.1007/s40121-021-00505-8 · Cited by 24
Dominant clade‐featured SARS‐CoV‐2 co‐occurring mutations reveal plausible epistasis: An in silico based hypothetical model
Alam, A. S. M. R. U., Islam, O. K., Hasan, M. S., Islam, M. R., Mahmud, S., Al‐Emran, H. M., Jahid, I. K., Crandall, K. A., & Hossain, M. A. (2021) · Journal of Medical Virology · doi:10.1002/jmv.27416 · Cited by 24
Variant-specific vaccination induces systems immune responses and potent in vivo protection against SARS-CoV-2
Peng, L., Renauer, P. A., Ökten, A., Fang, Z., Park, J. J., Zhou, X., Lin, Q., Dong, M. B., Filler, R., Xiong, Q., et al. (2022) · Cell Reports Medicine · doi:10.1016/j.xcrm.2022.100634 · Cited by 21
SARS-CoV-2 and COVID-19: A Narrative Review
Blann, A. D., & Heitmar, R. (2022) · British Journal of Biomedical Science · doi:10.3389/bjbs.2022.10426 · Cited by 25
Emergence of a Severe Acute Respiratory Syndrome Coronavirus 2 Virus Variant With Novel Genomic Architecture in Hong Kong
Tse, H., Lung, D. C., Wong, S. C. Y., Ip, K.-F., Wu, T.-C., To, K. K., Kok, K., Yuen, K., & Choi, G. K.-Y. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciab198 · Cited by 23
Emerging phylogenetic structure of the SARS-CoV-2 pandemic
Fountain‐Jones, N. M., Appaw, R. C., Carver, S., Didelot, X., Volz, E., & Charleston, M. (2020) · Virus Evolution · doi:10.1093/ve/veaa082 · Cited by 27
Clinical, Serological, Whole Genome Sequence Analyses to Confirm SARS-CoV-2 Reinfection in Patients From Mumbai, India
Shastri, J. S., Parikh, S., Agrawal, S. R., Chatterjee, N., Pathak, M., Chaudhary, S., Sharma, C., Kanakan, A., Vivekanand, A., Vasudevan, J. S., et al. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.631769 · Cited by 23
Determination of the Concentration of IgG against the Spike Receptor-Binding Domain That Predicts the Viral Neutralizing Activity of Convalescent Plasma and Serum against SARS-CoV-2
Santiago, L., Uranga-Murillo, I., Arias, M. A., González‐Ramírez, A. M., Macías‐León, J., Moreo, E., Redrado, S., García‐García, A., Taleb, V., Lira‐Navarrete, E., et al. (2021) · Biology · doi:10.3390/biology10030208 · Cited by 23
Severe acute respiratory syndrome coronavirus 2 escape mutants and protective immunity from natural infections or immunizations
Di, A., Cunha, F., Petrosillo, N., Beeching, N. J., Ergonul, O., Petersen, E., & Koopmans, M. (2021) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2021.03.011 · Cited by 24
A Novel SARS-CoV-2 Viral Sequence Bioinformatic Pipeline Has Found Genetic Evidence That the Viral 3′ Untranslated Region (UTR) Is Evolving and Generating Increased Viral Diversity
Farkas, C., Mella, A., Turgeon, M., & Haigh, J. J. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.665041 · Cited by 26
SARS-CoV-2 whole-genome sequencing using reverse complement PCR: For easy, fast and accurate outbreak and variant analysis.
Coolen, J. P. M., Wolters, F., Tostmann, A., van Groningen, L. F. J., Bleeker‐Rovers, C. P., Tan, E. C. T. H., van der Geest-Blankert, N., Hautvast, J. L. A., Hopman, J., Wertheim, H. F. L., et al. (2021) · Journal of Clinical Virology · doi:10.1016/j.jcv.2021.104993 · Cited by 22
Microorganisms as Shapers of Human Civilization, from Pandemics to Even Our Genomes: Villains or Friends? A Historical Approach
Rodríguez‐Frias, F., Quer, J., Tabernero, D., Cortese, M. F., García-García, S., Rando‐Segura, A., & Pumarola, T. (2021) · Microorganisms · doi:10.3390/microorganisms9122518 · Cited by 26
Genomic Surveillance Enables the Identification of Co-infections With Multiple SARS-CoV-2 Lineages in Equatorial Guinea
Hosch, S., Mpina, M., Nyakurungu, E., Silochi, N. B., Obama, T. M. A., Ovona, M. C., Wagner, P., Rubin, S. E., Vickos, U., Milang, D. V. N., et al. (2022) · Frontiers in Public Health · doi:10.3389/fpubh.2021.818401 · Cited by 23
Multiplex Target-Redundant RT-LAMP for Robust Detection of SARS-CoV-2 Using Fluorescent Universal Displacement Probes
Kline, E. C., Panpradist, N., Hull, I. T., Wang, Q., Oreskovic, A. K., Han, P. D., Starita, L. M., & Lutz, B. R. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.01583-21 · Cited by 23
Emergence and Spread of the SARS-CoV-2 Variant of Concern Delta across Different Brazilian Regions
Arantes, I., Naveca, F. G., Gräf, T., COVID-19 Fiocruz Genomic Surveillance Network, Miyajima, F., Faoro, H., Wallau, G. L., Delatorre, E. O., Appolinario, L., Pereira, E. C., et al. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.02641-21 · Cited by 23
Quantitative profiling of N-glycosylation of SARS-CoV-2 spike protein variants
Xie, Y., & Butler, M. (2023) · Glycobiology · doi:10.1093/glycob/cwad007 · Cited by 23
Patient and ward related risk factors in a multi-ward nosocomial outbreak of COVID-19: Outbreak investigation and matched case–control study
Leal, J. R., O’Grady, H. M., Armstrong, L., Dixit, D., Khawaja, Z., Snedeker, K. G., Ellison, J., Erebor, J., Jamieson, P. C., Weiss, A., et al. (2023) · Antimicrobial Resistance and Infection Control · doi:10.1186/s13756-023-01215-1 · Cited by 23
A framework for automated scalable designation of viral pathogen lineages from genomic data
McBroome, J., Schneider, A. D. B., Roemer, C., Wolfinger, M. T., Hinrichs, A. S., O’Toole, A. N., Ruis, C., Turakhia, Y., Rambaut, A., & Corbett-Detig, R. B. (2024) · Nature Microbiology · doi:10.1038/s41564-023-01587-5 · Cited by 23
Self-citation
Computational tools and data integration to accelerate vaccine development: challenges, opportunities, and future directions
Anderson, L. N., Hoyt, C. T., Zucker, J., McNaughton, A. D., Teuton, J., Karis, K., Arokium-Christian, N. N., Warley, J. T., Stromberg, Z. R., Gyori, B. M., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1502484 · Cited by 26
A comprehensive profile of genomic variations in the SARS-CoV-2 isolates from the state of Telangana, India
Gupta, A., Sabarinathan, R., Bala, P., Donipadi, V., Vashisht, D., Katika, M. R., Kandakatla, M., Mitra, D., Dalal, A. B., & Bashyam, M. D. (2021) · Journal of General Virology · doi:10.1099/jgv.0.001562 · Cited by 22
Investigation of a severe SARS-CoV-2 outbreak in a long-term care home early in the pandemic
Murti, M., Goetz, M., Saunders, A., Sunil, V., Guthrie, J. L., Eshaghi, A., Zittermann, S. I., Teatero, S., Fittipaldi, N., Rilkoff, H., et al. (2021) · Canadian Medical Association Journal · doi:10.1503/cmaj.202485 · Cited by 22
Importation, circulation, and emergence of variants of SARS-CoV-2 in the South Indian state of Karnataka
Pattabiraman, C., Prasad, P., George, A. K., Sreenivas, D., Rasheed, R., Reddy, N. V. K., Desai, A. S., & Ravi, V. (2021) · Wellcome Open Research · doi:10.12688/wellcomeopenres.16768.1 · Cited by 21
Comparative Analysis of Emerging B.1.1.7+E484K SARS-CoV-2 Isolates
Moustafa, A. M., Bianco, C. M., Denu, L., Ahmed, A., Coffin, S. E., Neide, B., Everett, J. K., Reddy, S. G., Rabut, E., Deseignora, J., et al. (2021) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofab300 · Cited by 23
Study on SARS-CoV-2 strains in Iran reveals potential contribution of co-infection with and recombination between different strains to the emergence of new strains
Taghizadeh, P., Salehi, S., Heshmati, A., Houshmand, S. M., InanlooRahatloo, K., Mahjoubi, F., Sanati, M. H., Yari, H., Alavi, A., Jamehdar, S. A., et al. (2021) · Virology · doi:10.1016/j.virol.2021.06.004 · Cited by 21
Real-Time Genomic Surveillance for SARS-CoV-2 Variants of Concern, Uruguay
Rego, N., Costábile, A., Paz, M., Salazar, C., Perbolianachis, P., Spangenberg, L., Ferrés, I., Arce, R., Fajardo, Á., Arleo, M., et al. (2021) · Emerging infectious diseases · doi:10.3201/eid2711.211198 · Cited by 21
Computational decomposition reveals reshaping of the SARS‐CoV‐2–ACE2 interface among viral variants expressing the N501Y mutation
Socher, E., Conrad, M., Heger, L., Paulsen, F. P., Sticht, H., Zunke, F., & Arnold, P. (2021) · Journal of Cellular Biochemistry · doi:10.1002/jcb.30142 · Cited by 22
Why are some coronavirus variants more infectious?
Mukherjee, R., & Satardekar, R. (2021) · Journal of Biosciences · doi:10.1007/s12038-021-00221-y · Cited by 23
An exploratory study on the propagation of SARS‐CoV‐2 variants: Omicron is the most predominant variant
Muthusami, R., & Saritha, K. (2022) · Journal of Medical Virology · doi:10.1002/jmv.27634 · Cited by 22
An Update on the Status of Vaccine Development for SARS-CoV-2 Including Variants. Practical Considerations for COVID-19 Special Populations
Kantarcıoğlu, B., Iqbal, O., Lewis, J., Carter, C. A., Singh, M., Lievano, F. A., Ligocki, M. A., Jeske, W. P., Adıgüzel, C., Gerotziafas, G., et al. (2022) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/10760296211056648 · Cited by 25
Mutation induced infection waves in diseases like COVID-19
Schwarzendahl, F. J., Grauer, J., Liebchen, B., & Löwen, H. (2022) · Scientific Reports · doi:10.1038/s41598-022-13137-w · Cited by 24
EXPRESSION OF CONCERN: The emergence, spread and vanishing of a French SARS‐CoV‐2 variant exemplifies the fate of RNA virus epidemics and obeys the Mistigri rule
Colson, P., Gautret, P., Delerce, J., Chaudet, H., Pontarotti, P., Forterre, P., Tola, R., Bedotto, M., Delorme, L., Bader, W., et al. (2022) · Journal of Medical Virology · doi:10.1002/jmv.28102 · Cited by 23
A machine learning approach identifies distinct early-symptom cluster phenotypes which correlate with hospitalization, failure to return to activities, and prolonged COVID-19 symptoms
Epsi, N. J., Powers, J. H., Lindholm, D. A., Mende, K., Malloy, A. M. W., Ganesan, A., Huprikar, N., Lalani, T., Smith, A. G., Mody, R. M., et al. (2023) · PLoS ONE · doi:10.1371/journal.pone.0281272 · Cited by 22
Rise and fall of SARS-CoV-2 variants in Rotterdam: Comparison of wastewater and clinical surveillance
Izquierdo-Lara, R. W., Heijnen, L., Munnink, B. B. O., Schapendonk, C. M. E., Elsinga, G., Langeveld, J., Post, J., Prasad, D. K., Carrizosa, C., Béen, F. M., et al. (2023) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2023.162209 · Cited by 26
Analysis of the ARTIC V4 and V4.1 SARS-CoV-2 primers and their impact on the detection of Omicron BA.1 and BA.2 lineage-defining mutations
Ulhuq, F. R., Barge, M., Falconer, K., Wild, J., Fernandes, G., Gallagher, A., McGinley, S., Sugadol, A., Tariq, M., Maloney, D. M., et al. (2023) · Microbial Genomics · doi:10.1099/mgen.0.000991 · Cited by 27
Public availability of HIV-1 drug resistance sequence and treatment data: a systematic review
Rhee, S., Kassaye, S., Jordan, M. R., Kouamou, V., Katzenstein, D. A., & Shafer, R. W. (2022) · The Lancet Microbe · doi:10.1016/s2666-5247(21)00250-0 · Cited by 20
Genomic Epidemiology of Severe Acute Respiratory Syndrome Coronavirus 2, Colombia
Laiton‐Donato, K., Villabona‐Arenas, C. J., Usme-Ciro, J. A., Franco-Muñoz, C., Álvarez-Díaz, D. A., Villabona-Arenas, L. S., Londono, S. E., Cucunubá, Z. M., Franco‐Sierra, N. D., Floréz, A. C., et al. (2020) · Emerging infectious diseases · doi:10.3201/eid2612.2969 · Cited by 22
[Epidemiology of HIV-associated malignancies].
Launay, O., & Guillevin, L. (2003) · PubMed · Cited by 22
A comparative analysis of SARS-CoV-2 antivirals in human airway models characterizes 3CL(pro) inhibitor PF-00835231 as a potential new treatment for COVID-19Preprint
de Vries, M., Mohamed, A., Prescott, R. A., Valero-Jimenez, A. M., Desvignes, L., O’Connor, R., Steppan, C. M., Devlin, J. C., Ivanova, E. N., Herrera, A. M., et al. (2021) · PubMed Central · doi:10.1101/2020.08.28.272880 · Cited by 14
Emergence of new subgenomic mRNAs in SARS-CoV-2Preprint
Mears, H. V., Young, G. R., Sanderson, T., Harvey, R., Crawford, M. R., Snell, D. M., Fowler, A. S., Hussain, S., Nicod, J., Peacock, T. P., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.04.20.488895 · Cited by 22
Travel-driven emergence and spread of SARS-CoV-2 lineage B.1.620 with multiple VOC-like mutations and deletions in Europe
Dudas, G., Hong, S. L., Potter, B., Calvignac-Spencer, S., Niatou-Singa, F. S., Tombolomako, T. B., Fuh-Neba, T., Vickos, U., Ulrich, M., Leendertz, F. H., et al. (2021) · doi:10.1101/2021.05.04.21256637 · Cited by 76
Wastewater surveillance of SARS-CoV-2 from aircraft to citywide monitoring
Pérez-Zabaleta, M., Berg, C., Latorre‐Margalef, N., Owusu-Agyeman, I., Kiyar, A., Botnen, H., Schönning, C., Hugerth, L. W., & Çetecioğlu, Z. (2025) · Nature Communications · doi:10.1038/s41467-025-60490-1 · Cited by 21
Prevalence and stability of SARS-CoV-2 RNA on Bangladeshi banknotes
Akter, S., Roy, P. C., Ferdaus, A., Ibnat, H., Alam, A. S. M. R. U., Nigar, S., Jahid, I. K., & Hossain, M. A. (2021) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2021.146133 · Cited by 21
Respiratory Viral Shedding in Healthcare Workers Reinfected with SARS-CoV-2, Brazil, 2020
Amorim, M. R., de Souza, W. M., Barros, A. C. G., de Toledo-Teixeira, D. A., Bispo-dos-Santos, K., Simeoni, C. L., Parise, P. L., Vieira, A., Forato, J., Claro, I. M., et al. (2021) · Emerging infectious diseases · doi:10.3201/eid2706.210558 · Cited by 21
The importance of genomic analysis in cracking the coronavirus pandemic
Zella, D., Giovanetti, M., Cella, E., Borsetti, A., Ciotti, M., Ceccarelli, G., d’Ettorre, G., Pezzuto, A., Tambone, V., Campanozzi, L. L., et al. (2021) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2021.1917998 · Cited by 23
Vaccine breakthrough infection and onward transmission of SARS-CoV-2 Beta (B.1.351) variant, Bavaria, Germany, February to March 2021
Kroidl, I., Mecklenburg, I., Schneiderat, P., Müller, K., Girl, P., Wölfel, R., Sing, A., Dangel, A., Wieser, A., & Höelscher, M. (2021) · Eurosurveillance · doi:10.2807/1560-7917.es.2021.26.30.2100673 · Cited by 21
The Role of Spike Protein Mutations in the Infectious Power of SARS‐COV‐2 Variants: A Molecular Interaction Perspective
Gómez, S. A., Rojas‐Valencia, N., Gómez, S., Cappelli, C., & Restrepo, A. A. (2021) · ChemBioChem · doi:10.1002/cbic.202100393 · Cited by 21
From Alpha to Zeta: Identifying Variants and Subtypes of SARS-CoV-2 Via Clustering
Melnyk, A., Mohebbi, F., Knyazev, S., Sahoo, B., Hosseini, R., Skums, P., Zelikovsky, A., & Patterson, M. (2021) · Journal of Computational Biology · doi:10.1089/cmb.2021.0302 · Cited by 21
SARS-CoV-2 B.1.619 and B.1.620 Lineages, South Korea, 2021
Park, A. K., Kim, I., Kim, H. M., Lee, H., Lee, N., Kim, J., Woo, S., Lee, C. Y., Lee, J., Oh, S. J., et al. (2022) · Emerging infectious diseases · doi:10.3201/eid2802.211653 · Cited by 21
Association between COVID-19 Diagnosis and Coronary Artery Thrombosis: A Narrative Review
Nappi, F., Giacinto, O., Ellouze, O., Nenna, A., Singh, S. S. A., Chello, M., Bouzguenda, A., & Copie, X. (2022) · Biomedicines · doi:10.3390/biomedicines10030702 · Cited by 22
Investigating the Extent of Primer Dropout in SARS-CoV-2 Genome Sequences During the Early Circulation of Delta Variants
Borcard, L., Gempeler, S., Miani, M. A. T., Baumann, C., Grädel, C., Dijkman, R., Suter‐Riniker, F., Leib, S. L., Bittel, P., Neuenschwander, S. M., et al. (2022) · Frontiers in Virology · doi:10.3389/fviro.2022.840952 · Cited by 21
Evolutionary history and introduction of SARS-CoV-2 Alpha VOC/B.1.1.7 in Pakistan through international travelers
Nasir, A., Bukhari, A. R., Trovão, N. S., Thielen, P., Kanji, A., Mahmood, S. F., Ghanchi, N. K., Ansar, Z., Merritt, B. B., Mehoke, T. S., et al. (2022) · Virus Evolution · doi:10.1093/ve/veac020 · Cited by 21
Comparison of different sequencing techniques for identification of SARS-CoV-2 variants of concern with multiplex real-time PCR
Ranasinghe, D., Jayadas, T. T. P., Jayathilaka, D., Jeewandara, C., Dissanayake, O., Guruge, D., Ariyaratne, D., Gunasinghe, D. N., Gomes, L., Wijesinghe, A., et al. (2022) · PLoS ONE · doi:10.1371/journal.pone.0265220 · Cited by 25
Emergence and spread of a sub-lineage of SARS-CoV-2 Alpha variant B.1.1.7 in Europe, and with further evolution of spike mutation accumulations shared with the Beta and Gamma variants
Stadtmüller, M., Laubner, A., Rost, F., Winkler, S., Patrasová, E., Šimůnková, L., Reinhardt, S., Beil, J., Dalpke, A. H., & Yi, B. (2022) · Virus Evolution · doi:10.1093/ve/veac010 · Cited by 24
On Classification and Taxonomy of Coronaviruses (Riboviria, Nidovirales, Coronaviridae) with Special Focus on Severe Acute Respiratory Syndrome-Related Coronavirus 2 (SARS-CoV-2)
Mavrodiev, E. V., Tursky, M. L., Mavrodiev, N. E., Schroder, L., Laktionov, A. P., Ebach, M. C., & Williams, D. M. (2022) · Mathematical Biology and Bioinformatics · doi:10.17537/2022.17.289 · Cited by 21
Identification of herbal teas and their compounds eliciting antiviral activity against SARS-CoV-2 in vitro
Le‐Trilling, V. T. K., Mennerich, D., Schuler, C., Sakson, R., Lill, J. K., Kasarla, S. S., Kopczynski, D., Loroch, S., Flores-Martinez, Y., Katschinski, B., et al. (2022) · BMC Biology · doi:10.1186/s12915-022-01468-z · Cited by 21
Rapid, high-throughput, cost-effective whole-genome sequencing of SARS-CoV-2 using a condensed library preparation of the Illumina DNA Prep kit
Hickman, R., Nguyen, J., Lee, T. D., Tyson, J. R., Azana, R. B., Tsang, F., Hoang, L., & Prystajecky, N. (2024) · Journal of Clinical Microbiology · doi:10.1128/jcm.00103-22 · Cited by 21
Phylogenetic-based methods for fine-scale classification of PRRSV-2 ORF5 sequences: a comparison of their robustness and reproducibility
VanderWaal, K. L., Pamornchainavakul, N., Kikuti, M., Linhares, D. C. L., Trevisan, G., Zhang, J., Anderson, T. K., Zeller, M. A., Rossow, S., Holtkamp, D., et al. (2024) · Frontiers in Virology · doi:10.3389/fviro.2024.1433931 · Cited by 21
V-pipe 3.0: a sustainable pipeline for within-sample viral genetic diversity estimation
Fuhrmann, L., Jablonski, K. P., Topolsky, I., Batavia, A. A., Borgsmüller, N., Baykal, P. I., Carrara, M., Chen, C., Dondi, A., Dragan, M., et al. (2024) · GigaScience · doi:10.1093/gigascience/giae065 · Cited by 20
Characterization of local SARS-CoV-2 isolates and pathogenicity in IFNAR−/- mice
Hanifehnezhad, A., Kehribar, E. Ş., Öztop, S., Sheraz, A., Kasırga, T. S., Ergünay, K., Onder, S. C., Yılmaz, E., Engin, D., Oğuzoğlu, T. Ç., et al. (2020) · Heliyon · doi:10.1016/j.heliyon.2020.e05116 · Cited by 20
COVID-19 outbreak in Malaysia: Decoding D614G mutation of SARS-CoV-2 virus isolated from an asymptomatic case in Pahang
Yassim, A. S. M., Asras, M. F. F., Gazali, A. M., Marcial-Coba, M. S., Zainulabid, U. A., & Ahmad, H. F. (2021) · Materials Today Proceedings · doi:10.1016/j.matpr.2021.02.387 · Cited by 20
Whole-genome sequencing of SARS-CoV-2 in the Republic of Ireland during waves 1 and 2 of the pandemicPreprint
Mallon, P. W. G., Crispie, F., Gonzalez, G., Tinago, W., Leon, A. A. G., McCabe, M. S., de Barra, E., Yousif, O., Lambert, J. S., Walsh, C. J., et al. (2021) · medRxiv · doi:10.1101/2021.02.09.21251402 · Cited by 19
Artificial Intelligence in Infectious Disease Diagnostic Technologies
Dong, C., Liu, Y., Nie, J., Zhang, X., Yu, F., & Zhou, Y.-F. (2025) · Diagnostics · doi:10.3390/diagnostics15202602 · Cited by 27
Phylogenetic analysis of SARS-CoV-2 genomes in Turkey
Adebalı, O., Bırcan, A., Çırcı, D., İşlek, B., Kilinç, Z., Selçuk, B., & Turhan, B. (2020) · TURKISH JOURNAL OF BIOLOGY · doi:10.3906/biy-2005-35 · Cited by 20
Rapid spread and high impact of the variant of concern P.1 in the largest city of Brazil
Barbosa, G. R., Moreira, L. V. L., Justo, A. F. O., Perosa, A. H., Luna, L. K. D. S., Chaves, A. P. C., Bueno, M. S., Conte, D., Carvalho, J. M. A., Prates, J., et al. (2021) · Journal of Infection · doi:10.1016/j.jinf.2021.04.008 · Cited by 20
Whole-genome sequencing of SARS-CoV-2 in Uganda: implementation of the low-cost ARTIC protocol in resource-limited settings
Mboowa, G., Mwesigwa, S., Kateete, D. P., Wayengera, M., Nasinghe, E., Katagirya, E., Katabazi, A. F., Kigozi, E., Kirimunda, S., Kamulegeya, R., et al. (2021) · F1000Research · doi:10.12688/f1000research.53567.1 · Cited by 20
Emergence and Spread of B.1.1.7 Lineage in Primary Care and Clinical Impact in the Morbi-Mortality among Hospitalized Patients in Madrid, Spain
Martínez-García, L., Ruíz, M. A. E., Abreu, M., González‐Alba, J. M., Gijón-Cordero, D., Laso, A. M., Cantón, R., Galán, J. C., & Andrés, J. M. A. (2021) · Microorganisms · doi:10.3390/microorganisms9071517 · Cited by 18
The Evolving Faces of the SARS-CoV-2 Genome
Schmidt, M., Arshad, M., Bernhart, S. H., Hakobyan, S., Arakelyan, A., Loeffler‐Wirth, H., & Binder, H. (2021) · Viruses · doi:10.3390/v13091764 · Cited by 19
SARS-CoV-2 B.1.1.7 lineage rapidly spreads and replaces R.1 lineage in Japan: Serial and stationary observation in a community
Hirotsu, Y., & Omata, M. (2021) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2021.105088 · Cited by 20
Household Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Alpha Variant—United States, 2021
Donnelly, M. A. P., Chuey, M. R., Soto, R. A., Schwartz, N. G., Chu, V. T., Konkle, S. L., Sleweon, S., Ruffin, J. D., Haberling, D. L., Guagliardo, S. A. J., et al. (2022) · Clinical Infectious Diseases · doi:10.1093/cid/ciac125 · Cited by 20
Neutralisation Hierarchy of SARS-CoV-2 Variants of Concern Using Standardised, Quantitative Neutralisation Assays Reveals a Correlation With Disease Severity; Towards Deciphering Protective Antibody Thresholds
Cantoni, D. M., Neto, M. M., Nadesalingam, A., Wells, D. A., Carnell, G., Ohlendorf, L., Ferrari, M., Palmer, P., Chan, A. C. Y., Smith, P., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.773982 · Cited by 20
Dominance of Three Sublineages of the SARS-CoV-2 Delta Variant in Mexico
Taboada, B., Zárate, S., Muñoz‐Medina, J. E., Sánchez‐Flores, A., García-López, R., Herrera‐Estrella, A., Boukadida, C., Gómez‐Gil, B., Mojica, N. S., Rosales-Rivera, M., et al. (2022) · Viruses · doi:10.3390/v14061165 · Cited by 20
Sequential Appearance and Isolation of a SARS-CoV-2 Recombinant between Two Major SARS-CoV-2 Variants in a Chronically Infected Immunocompromised Patient
Burel, E., Colson, P., Lagier, J., Levasseur, A., Bedotto, M., Lavrard, P., Fournier, P., Scola, B. L., & Raoult, D. (2022) · Viruses · doi:10.3390/v14061266 · Cited by 20
Host genetic loci LZTFL1 and CCL2 associated with SARS-CoV-2 infection and severity of COVID-19
Rüter, J., Pallerla, S. R., Meyer, C. G., Casadei, N., Sonnabend, M., Peter, S., Nurjadi, D., Linh, L. T. K., Fendel, R., Göpel, S., et al. (2022) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2022.06.030 · Cited by 20
Altered subgenomic RNA abundance provides unique insight into SARS-CoV-2 B.1.1.7/Alpha variant infections
Parker, M. D., Stewart, H., Shehata, O. M., Lindsey, B. B., Shah, D. R., Hsu, S. N., Keeley, A. J., Partridge, D. G., Leary, S., Cope, A., et al. (2022) · Communications Biology · doi:10.1038/s42003-022-03565-9 · Cited by 49
Using multiple sampling strategies to estimate SARS-CoV-2 epidemiological parameters from genomic sequencing data
Inward, R. P. D., Parag, K. V., & Faria, N. R. (2022) · Nature Communications · doi:10.1038/s41467-022-32812-0 · Cited by 20
The Comparison of Mutational Progression in SARS-CoV-2: A Short Updated Overview
Asif, A., Ilyas, I., Abdullah, M., Sarfraz, S., Mustafa, M., & Mahmood, A. (2022) · Journal of Molecular Pathology · doi:10.3390/jmp3040018 · Cited by 20
Emergence and pandemic spread of small ruminant lentiviruses
Carrozza, M., Niewiadomska, A.-M., Mazzei, M., Abi-Said, M. R., Hué, S., Hughes, J., Gatseva, A., & Gifford, R. J. (2023) · Virus Evolution · doi:10.1093/ve/vead005 · Cited by 30
Mutational signature dynamics indicate SARS-CoV-2’s evolutionary capacity is driven by host antiviral molecules
Lamb, K. D., Luka, M. M., Saathoff, M., Orton, R. J., Phan, M. V. T., Cotten, M. L., Yuan, K., & Robertson, D. L. (2024) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1011795 · Cited by 26
Understanding Coronavirus
Rabadán, R. (2020) · Cambridge University Press eBooks · doi:10.1017/9781009090063 · Cited by 20
Molecular Analysis of SARS-CoV-2 Genetic Lineages in Jordan: Tracking the Introduction and Spread of COVID-19 UK Variant of Concern at a Country Level
Sallam, M., & Mahafzah, A. M. (2021) · Pathogens · doi:10.3390/pathogens10030302 · Cited by 23
SARS-CoV-2 variants lacking ORF8 occurred in farmed mink and pangolin
Pereira, F. (2021) · Gene · doi:10.1016/j.gene.2021.145596 · Cited by 19
A new SARS-CoV-2 variant with high lethality poorly detected by RT-PCR on nasopharyngeal samples: an observational study
Fillâtre, P., Dufour, M.-J., Behillil, S., Vatan, R., Reusse, P., Gabellec, A., Velmans, N., Montagne, C., Coudret, S. G. D., Droumaguet, E., et al. (2021) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2021.09.035 · Cited by 21
Vaccine Breakthrough Infections by SARS-CoV-2 Variants after ChAdOx1 nCoV-19 Vaccination in Healthcare Workers
Kale, P. R., Gupta, E., Bihari, C., Patel, N., Rooge, S. B., Pandey, A. K., Bajpai, M., Khillan, V., Chattopadhyay, P., Devi, P., et al. (2021) · Vaccines · doi:10.3390/vaccines10010054 · Cited by 20
‘A bloody mess’: Confusion reigns over naming of new COVID variants
Callaway, E. (2021) · Nature · doi:10.1038/d41586-021-00097-w · Cited by 21
Metagenomic sequencing of municipal wastewater provides a near-complete SARS-CoV-2 genome sequence identified as the B.1.1.7 variant of concern from a Canadian municipality concurrent with an outbreakPreprint
Landgraff, C., Wang, L. Y. R., Buchanan, C. J., Wells, M., Schonfeld, J., Bessonov, K., Ali, J., Robert, E., & Nadon, C. A. (2021) · medRxiv · doi:10.1101/2021.03.11.21253409 · Cited by 22
The unique evolutionary dynamics of the SARS-CoV-2 Delta variantPreprint
Stern, A., Fleishon, S., Kustin, T., Dotan, E., Mandelboim, M., Erster, O., Mendelson, E., Mor, O., & Zuckerman, N. S. (2021) · medRxiv · doi:10.1101/2021.08.05.21261642 · Cited by 23
SARS-CoV-2 infection in free-ranging white-tailed deer ( Odocoileus virginianus )Preprint
Hale, V. L., Dennis, P. M., McBride, D. S., Nolting, J. M., Madden, C. C., Huey, D. D., Ehrlich, M., Grieser, J. M., Winston, J. A., Lombardi, D., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.11.04.467308 · Cited by 20

Authors: Rambaut, A., Holmes, E. C., O’Toole, Á., Hill, V., McCrone, J. T., Ruis, C., du Plessis, L., & Pybus, O. G.
Affiliations: University of Edinburgh (GB)
The University of Sydney (AU)
University of Cambridge (GB)
University of Oxford (GB)
Corresponding author: Rambaut, Andrew
Holmes, Edward C.
Pybus, Oliver G.
ORCID: Rambaut, Andrew
Holmes, Edward C.
O’Toole, Áine
Hill, Verity
McCrone, John T.
Ruis, Christopher
du Plessis, Louis
Pybus, Oliver G.
Venue: Nature Microbiology
Publisher: Springer Science and Business Media LLC
Published: 2020-07-15
Volume: 5
Issue: 11
Pages: 1403-1407
ISSN: 2058-5276 (ISSN-L)
DOI: 10.1038/s41564-020-0770-5
PMC: PMC7610519
OpenAlex: W3043124965
Cited by: 2,543
References: 18
Citations by year: 2026: 86 · 2025: 141 · 2024: 235 · 2023: 365 · 2022: 700 · 2021: 851 · 2020: 163
FWCI: 68.76
Type: journal article
Language: en
Update notices: addendum (2021-01-29)
Open access: bronze
doi.org
Licence: www.springernature.com/gp/researchers/text-and-data-mining (tdm)
www.springernature.com/gp/researchers/text-and-data-mining (vor)
Locations: Nature Microbiology (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, other-oa)
The Sydney eScholarship Repository (The University of Sydney) (submittedVersion)
Funders: Wellcome Trust (206298/Z/17/Z-ARTIC, FP7/2007–2013, Z/17/Z, 206298/Z/17/Z, 206298, 725422-ReservoirDOCS)
European Commission (725422, 725422-RESERVOIRDOCS, 2007–2013, FP7 2007-2013, HORIZON2020, FP7/2007, COVID-19)
Australian Research Council (FL170100022)
FP7 Ideas: European Research Council (614725)
Topics: Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Phylogenetic Studies
Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 detection and testing
Keywords: SARS-CoV-2, COVID-19 pandemic, virus nomenclature, phylogenetic lineages, genomic epidemiology
MeSH terms: Betacoronavirus, COVID-19, SARS-CoV-2, Genotype, Humans, Phylogeny, Pneumonia, Viral, Genome, Viral, Molecular Epidemiology, Coronavirus Infections, Pandemics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks